Hilltop Holdings Inc. acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 355 shares of the medical equipment provider’s stock, valued at approximately $210,000.
A number of other institutional investors have also recently made changes to their positions in the stock. Wealthspire Advisors L.P. increased its position in Intuitive Surgical by 2.4% during the fourth quarter. Wealthspire Advisors L.P. now owns 736 shares of the medical equipment provider’s stock worth $435,000 after buying an additional 17 shares during the last quarter. Dubuque Bank & Trust Co. boosted its holdings in Intuitive Surgical by 2.1% in the 4th quarter. Dubuque Bank & Trust Co. now owns 858 shares of the medical equipment provider’s stock valued at $507,000 after purchasing an additional 18 shares during the period. Calamos Wealth Management LLC grew its position in Intuitive Surgical by 2.1% during the fourth quarter. Calamos Wealth Management LLC now owns 884 shares of the medical equipment provider’s stock worth $523,000 after buying an additional 18 shares in the last quarter. Lindbrook Capital LLC lifted its position in Intuitive Surgical by 3.6% during the fourth quarter. Lindbrook Capital LLC now owns 521 shares of the medical equipment provider’s stock worth $308,000 after purchasing an additional 18 shares during the period. Finally, Moody Lynn & Lieberson LLC boosted its position in shares of Intuitive Surgical by 0.3% during the 4th quarter. Moody Lynn & Lieberson LLC now owns 6,217 shares of the medical equipment provider’s stock worth $3,675,000 after acquiring an additional 18 shares in the last quarter. 85.52% of the stock is currently owned by institutional investors and hedge funds.
Shares of Intuitive Surgical stock opened at $460.31 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $360.50 and a 52-week high of $619.00. The stock has a market capitalization of $50.42 billion, a price-to-earnings ratio of 39.85, a P/E/G ratio of 4.11 and a beta of 1.10. The company’s 50 day moving average price is $535.21 and its 200-day moving average price is $556.15.
Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 23rd. The medical equipment provider reported $3.48 EPS for the quarter, beating analysts’ consensus estimates of $3.38 by $0.10. Intuitive Surgical had a return on equity of 18.16% and a net margin of 30.80%. The business had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the prior year, the company posted $2.96 EPS. Intuitive Surgical’s quarterly revenue was up 22.1% compared to the same quarter last year. Analysts forecast that Intuitive Surgical, Inc. will post 9.77 earnings per share for the current year.
In related news, Director Alan J. Levy sold 1,950 shares of the business’s stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $575.00, for a total transaction of $1,121,250.00. Following the sale, the director now owns 9,527 shares of the company’s stock, valued at $5,478,025. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Jamie Samath sold 1,492 shares of the business’s stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $600.00, for a total transaction of $895,200.00. Following the sale, the senior vice president now directly owns 540 shares in the company, valued at approximately $324,000. The disclosure for this sale can be found here. Insiders have sold 19,514 shares of company stock worth $11,229,904 over the last three months. Insiders own 1.60% of the company’s stock.
ISRG has been the subject of several research reports. Wells Fargo & Co reiterated an “overweight” rating and issued a $655.00 target price (up from $620.00) on shares of Intuitive Surgical in a research report on Monday, December 9th. Raymond James increased their target price on shares of Intuitive Surgical from $615.00 to $660.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Canaccord Genuity restated a “buy” rating on shares of Intuitive Surgical in a report on Friday, January 24th. Morgan Stanley boosted their price target on shares of Intuitive Surgical from $620.00 to $670.00 and gave the stock an “overweight” rating in a research report on Tuesday, December 17th. Finally, Deutsche Bank cut Intuitive Surgical from a “buy” rating to a “hold” rating and reduced their price objective for the company from $610.00 to $595.00 in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $607.67.
Intuitive Surgical Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Featured Story: Net Margin – Understanding the Different Kinds of Profit
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.